Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A REtrospective Non-interventional Study to Assess the Effectiveness of AfLibercept in Patients With Myopic CNV

NCT04524910 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04524910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A REtrospective Non-interventional Study to Assess the Effectiveness of AfLibercept in Patients With Myopic CNV
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 16, 2021
Completion date
November 11, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopic choroidal neovascularization